dw a 2114r has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, C; Saito, M; Yoshida, T | 1 |
| Chung, YS; Kato, Y; Kubo, T; Maeda, K; Nakata, B; Nitta, A; Okuno, M; Sowa, M; Yashiro, M | 1 |
| Arai, Y; Hashimura, T; Kamoto, T; Matsuda, T; Oishi, K; Takeuchi, H; Yoshida, O | 1 |
3 other study(ies) available for dw a 2114r and Adenocarcinoma
| Article | Year |
|---|---|
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
[Experimental study on the anti-tumor effect of CDDP derivatives against the gastric cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Humans; Organoplatinum Compounds; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |
[Treatment of endocrine-resistant stage D carcinoma of the prostate with a cisplatin derivative (DWA2114R): a pilot study].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Pilot Projects; Prostatic Neoplasms; Remission Induction; Treatment Failure | 1992 |